Virtus Investment Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,063
Closed -$786K 634
2024
Q4
$786K Hold
10,063
0.62% 36
2024
Q3
$726K Sell
10,063
-2,400
-19% -$170K 0.57% 48
2024
Q2
$858K Sell
12,463
-9,900
-44% -$671K 0.73% 30
2024
Q1
$1.62M Hold
22,363
1.16% 12
2023
Q4
$1.37M Sell
22,363
-6,200
-22% -$368K 1.03% 15
2023
Q3
$1.63M Sell
28,563
-952
-3% -$57.5K 1.11% 14
2023
Q2
$1.75M Hold
29,515
1.19% 9
2023
Q1
$1.85M Sell
29,515
-1,107
-4% -$69.1K 1.29% 9
2022
Q4
$1.92M Hold
30,622
1.28% 9
2022
Q3
$1.53M Buy
+30,622
New +$1.7M 0.7% 11

Other funds holding PBH

Virtus Investment Advisers's PBH Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Prestige Consumer Healthcare (PBH) in Q1 2025, closing a stake of 10,063 shares — an estimated $786K sold.

Virtus Investment Advisers first reported a position in PBH in Q3 2022 and held it in 10 quarters. The position peaked at $1.92M in Q4 2022. 359 funds tracked by Wall St. Rank hold PBH as of Q1 2025.

  • Virtus Investment Advisers reported no remaining Prestige Consumer Healthcare position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 10,063 Prestige Consumer Healthcare shares in Q1 2025, an estimated $786K.
  • Virtus Investment Advisers first reported a position in Prestige Consumer Healthcare in Q3 2022 and held it in 10 quarters.
  • Virtus Investment Advisers's Prestige Consumer Healthcare position peaked at $1.92M in Q4 2022.
  • 359 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.